AI-driven wearable bioelectronics enable continuous monitoring of cardiac activity, glucose and biomarkers to support early disease detection, chronic disease management and remote patient monitoring.
As of the June 2025 review, integration of AI with wearable bioelectronics was presented as enabling proactive, personalized monitoring of cardiac activity, glucose levels and biomarkers, with applications in early detection, chronic condition management and precision therapeutics.
- Impact 30%
- 49
- Evidence 25%
- 100
- Scale 20%
- 35
- Confidence 15%
- 99
- Recency 10%
- 85
Updated Jul 23, 2026 · TRV-2026-0520
ace